Key result
A localized bullous fixed drug eruption suspected to be induced by ticagrelor resolved after discontinuing the drug and transitioning to clopidogrel and rivaroxaban.
Case Report (n=1)
No
Ticagrelor can rarely cause a localized bullous fixed drug eruption, which resolves upon discontinuation and switching to alternative antithrombotic therapy.
Alerts clinicians to rare ticagrelor skin reactions; case report leaves open incidence and causality.
We describe a case of a suspected cutaneous hypersensitivity reaction to ticagrelor. The patient displayed a localized bullous fixed drug eruption after being loaded with ticagrelor, which resolved with oral antihistamines and topical steroids after one week. Clopidogrel and rivaroxaban were successfully administered as alternative antithrombotic therapy without any apparent further hypersensitivity skin reaction.
No takes yet. Share an insight, caveat, or question.
Kawall et al. (2021) conducted a case report in Acute Coronary Syndrome / Suspected ticagrelor-induced bullous fixed drug eruption (n=1). Ticagrelor was evaluated on Resolution of hypersensitivity reaction. A localized bullous fixed drug eruption suspected to be induced by ticagrelor resolved after discontinuing the drug and transitioning to clopidogrel and rivaroxaban.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: